Long-term voice and swallowing outcomes for oral and oropharyngeal cancer following primary or adjuvant chemoradiation
Annals of Otology, Rhinology & Laryngology Aug 22, 2019
Soldatova L, et al. - Because nonlaryngeal head and neck cancer (HNC) chemoradiation (CRT) can lead to voice and swallowing dysfunction, researchers studied voice and swallowing from the patient’s view at least 5 years after treatment. Study participants included 28 patients treated with primary or adjuvant CRT at least 5 years ago (mean = 10.7 years, SD = 5.5, range, 5-28) who completed a survey based on previously validated questionnaires. According to results, some voice and swallowing dysfunction were reported by patients. For nonlaryngeal HNC, perceived voice and swallowing dysfunction after CRT may continue or worsen beyond 5 years.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries